In summary, our study established a specific HIF-1 score system to discriminate pancreatic cancers with various degrees of hypoxia status and immunosuppressive TMEs, which provides accurate predictive value for patient prognoses. The gene discussed is HIF1A; the disease is familial pancreatic carcinoma.